Tuesday, November 26, 2013
Over the past decade, pharmaceutical and biotechnology
companies have increased their use of contractors for
biopharmaceutical production. This includes both the production
of drug substances as well as drug products. Over the next few years,
...
Thursday, November 29, 2012
The market demands for higher productivity and lower costs have led biopharmaceutical contract manufacturers (CMOs) to investigate and adopt new, sometimes disruptive, process technologies. CMOs continue to invest in upstream and downstream process ...
Thursday, September 01, 2011
The market for biopharmaceuticals continues to expand in both volume and revenue.
The manufacture of a biopharmaceutical is a complex process with many steps and materials used throughout the operation. While we often view certain key materials, such as cell culture media, chromatography resin or filling vials, as critical ...